(Total Views: 107)
Posted On: 02/02/2023 3:40:48 PM
Post# of 27272

$VSTM News Article - Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers https://marketwirenews.com/news-releases/vera...88881.html


My Twitter: WhyteStocks